Yubo International Biotech (YBGJ) Stock Price, News & Analysis

Company Overview

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.04 to $0.09
• 52-Week Range: $0.03 to $1.37
• Volume: N/A
• Average Volume: 11,471 shs
• Market Capitalization: $7.33 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YBGJ Stock Analysis - Frequently Asked Questions

How have YBGJ shares performed this year?

Yubo International Biotech's stock was trading at $0.0347 on January 1st, 2025. Since then, YBGJ stock has increased by 76.2% and is now trading at $0.0612.
View the best growth stocks for 2025 here.

How do I buy shares of Yubo International Biotech?

Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yubo International Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yubo International Biotech investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Company Calendar

• Today: 5/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:YBGJ
• CIK: 895464
• Web: www.yubogroup.com
• Phone: (640) 677-6010
• Fax: 516-595-1159
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,200,000.00
• Net Margins: N/A
• Pretax Margin: -8,254.97%
• Return on Equity: N/A
• Return on Assets: -121.41%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $610,000.00
• Price / Sales: 12.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -3.06

Miscellaneous

• Outstanding Shares: 119,821,000
• Free Float: 52,146,000
• Market Cap: $7.33 million
• Optionable: Not Optionable
• Beta: 4.17